Skip to content

Aptamer Group win four new contracts

07/07/2023 Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today provides an update on recent…

Aptamers as protein-protein interaction inhibitors

Protein-protein interactions were once considered undruggable. Our tailored aptamer selection approach is proving this isn’t so. Targets such as transcription factors, immune checkpoints in oncology, infectious disease agents, and…

Celebrating DNA aptamers on DNA Day!

April 25th is DNA day. This day celebrates the completion of the Human Genome Project 20 years ago and the discovery of DNA’s double helix 70 years ago,…